We are live on
!
Find out more
FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
223 hedge funds and large institutions have $3.48B invested in Amicus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 74 increasing their positions, 80 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.68% less ownership
Funds ownership: 109.87% → 108.19% (-1.7%)
6% less funds holding
Funds holding: 236 → 223 (-13)
30% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 37
Holders
223
Holding in Top 10
7
Calls
$9.67M
Puts
$3.91M
Top Buyers
| 1 | +$31.2M | |
| 2 | +$26.2M | |
| 3 | +$23M | |
| 4 |
Morgan Stanley
New York
|
+$21.8M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$21.4M |
Top Sellers
| 1 | -$15M | |
| 2 | -$14.5M | |
| 3 | -$13M | |
| 4 |
Goldman Sachs
New York
|
-$8.81M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$8.47M |